Successful docetaxel rechallenge with cromoglycate after major sensitivity reactions.
Westermann
A M
AM
ten Bokkel Huinink
W W
WW
Rodenhuis
S
S
D000284:Administration, Oral; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy; D004205:Cromolyn Sodium / Q000627:therapeutic use*; D000077143:Docetaxel; D004342:Drug Hypersensitivity / Q000209:etiology* / Q000517:prevention & control*; D005260:Female; D006801:Humans; D008875:Middle Aged; D017239:Paclitaxel / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D043823:Taxoids
D018927:Anti-Asthmatic Agents; D000972:Antineoplastic Agents, Phytogenic; D043823:Taxoids; D000077143:Docetaxel; D017239:Paclitaxel; D004205:Cromolyn Sodium